Home Acino

Acino

acquired
-
Innovative Drug Developer
Basic
Enterprise Profile

Basic Information

Acino, as a Swiss pharmaceutical company headquartered in Zurich, develops, manufactures, and markets internationally proven innovative drugs through novel drug delivery forms. We are leaders in advanced drug delivery technologies, specializing in extended-release oral formulations and orally disintegrating formulations.
Acino International AG
Zurich,Zurich,Switzerland
more than 500 people
January 01, 1836
info@acino.swiss

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs